Marker Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $18.3M | $45.6M | $21.4M |
| FY2021 | $24.1M | $68.1M | $42.4M |
| FY2022 | $14.8M | $34.4M | $11.8M |
| FY2023 | $3.1M | $17.1M | $15.1M |
| FY2024 | $3.5M | $22.0M | $19.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $18.3M | $45.6M | $21.4M |
| FY2021 | $24.1M | $68.1M | $42.4M |
| FY2022 | $14.8M | $34.4M | $11.8M |
| FY2023 | $3.1M | $17.1M | $15.1M |
| FY2024 | $3.5M | $22.0M | $19.2M |